Milan (ots/PRNewswire) - The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology. Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM(TM) S-ICD System as the most innovative ...
Natick, Massachusetts (ots/PRNewswire) - Innovative Stent Solution to treat patients with Critical Limb Ischemia Boston Scientific has launched in European countries the PROMUS ELEMENT(TM) PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certain severe peripheral artery lesions. The Drug Eluting Stent (DES) has CE Mark approval for both ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System in patients with the system and are in need for magnetic resonance imaging (MRI) head-only scans. The PRECISION PLUS SCS System is the world's first rechargeable SCS device. This approval provides physicians with an ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System, the world's first rechargeable SCS device, in peripheral nerve stimulation for patients with chronic intractable pain of the trunk. Peripheral nerve stimulation ...
Paris and Miami Beach, Florida (ots/PRNewswire) - Boston Scientific Corporation announces CE Mark approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device for chronic pain management. The first patient implant in Europe using ...
Paris, November 15 (ots/PRNewswire) - CRI's Amigo(TM) system allows remote control of Boston Scientific's leading cardiac ablation catheters Boston Scientific Corporation is beginning to market the CRI Amigo(TM) system, a remote-controlled catheter system, and related accessories in select European countries through ...
Paris, November 9 (ots/PRNewswire) - Now available for endoscopic dilation of the Sphincter of Oddi following sphincterotomy Boston Scientific Corporation's CRE(TM) Wireguided Balloon Dilator is now CE marked for endoscopic dilation of the Sphincter of Oddi following sphincterotomy. The new indication, which supplements the product's current indication for use in the ...
Paris (ots/PRNewswire) - - New Design Offers Greater Flexibility in the Management of Patients With Complex Atherosclerosis Boston Scientific Corporation (NYSE: BSX) announced today that the Apex(TM) Monorail and Over-The-Wire (OTW) PTCA dilatation catheters have received CE Mark approval. Both Monorail and OTW catheters are available in two designs to ...
Paris (ots/PRNewswire) - - Data From Multicentre Registry Show Significant Benefit With Closed-Cell Stents in the Treatment of Carotid Artery Stenosis Boston Scientific Corporation (NYSE: BSX) welcomed results from a large independent registry confirming the benefit of closed-cell stents in patients with carotid artery stenosis. The results, published in the ...
Natick, Massachusetts (ots/PRNewswire) - Boston Scientific Corporation (NYSE: BSX) today welcomed the results of two studies and an editorial published in today's edition of The New England Journal of Medicine (NEJM), all of which reaffirmed the safety and efficacy of drug-eluting stents. Commenting on the ...
Natick, Massachusetts and Paris (ots/PRNewswire) - - New Second-Generation Training Center in Brussels to Help Medical Professionals Advance Standard of Patient Care Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in ...
Natick, Massachusetts (ots/PRNewswire) - - Results to Include Nine-Month Data on TAXUS(R) Liberte(TM) Stent Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR), which runs from May ...
Natick, Massachusetts (ots/PRNewswire) - Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a global leader in cardiovascular devices and one of the largest medical technology companies in the world. In a related transaction before the closing of the Boston Scientific-Guidant transaction, Guidant and Abbott closed ...